You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 29, 2024

Details for Patent: 11,779,552


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 11,779,552 protect, and when does it expire?

Patent 11,779,552 protects ORSERDU and is included in one NDA.

This patent has eighteen patent family members in fourteen countries.


Drugs Protected by US Patent 11,779,552

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Stemline Therap ORSERDU elacestrant dihydrochloride TABLET;ORAL 217639-001 Jan 27, 2023 RX Yes No ⤷  Subscribe ⤷  Subscribe TREATMENT OF AN ER-POSITIVE BREAST CANCER FOLLOWING AT LEAST ONE LINE OF ENDOCRINE THERAPY ⤷  Subscribe
Stemline Therap ORSERDU elacestrant dihydrochloride TABLET;ORAL 217639-002 Jan 27, 2023 RX Yes Yes ⤷  Subscribe ⤷  Subscribe TREATMENT OF AN ER-POSITIVE BREAST CANCER FOLLOWING AT LEAST ONE LINE OF ENDOCRINE THERAPY ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 11,779,552

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 3122426 ⤷  Subscribe CA 2024 00007 Denmark ⤷  Subscribe
European Patent Office 3122426 ⤷  Subscribe 2024C/505 Belgium ⤷  Subscribe
European Patent Office 3122426 ⤷  Subscribe 301263 Netherlands ⤷  Subscribe
European Patent Office 3122426 ⤷  Subscribe LUC00331 Luxembourg ⤷  Subscribe
European Patent Office 3122426 ⤷  Subscribe PA2024504 Lithuania ⤷  Subscribe
European Patent Office 3122426 ⤷  Subscribe 122024000013 Germany ⤷  Subscribe
European Patent Office 3122426 ⤷  Subscribe 3/2024 Austria ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.